In truth, the evidence for HBOT therapy is robust, while the evidence for most of our dressings and devices is based on poorly conducted trials, case studies, or simple opinion. HBOT for diabetic foot ulcers has been confirmed by four randomized controlled trials (RCTs) with more research underway.... More is known about the mechanism of action of oxygen under pressure than the majority of adjunct therapies.
Bang. He had us at hello, with that quote from G. K. Chesterton. Serena also leads the Serena Group and is vice president of the ACHM, where he is a 2011 Masters Recipient and leads the ACES diabetic foot ulcer registry. (See our 9/2009 post, "Diabetic Foot Ulcer: New ACHM Registry Is ACES.") Now he's got us wondering how ACES is coming along.
O2.0 is the news blog of HyperbaricLink, the independent web guide to hyperbaric oxygen therapy.